You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BMS-936558

Showing 1 - 25 of 1,150
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

Completed
  • Melanoma (Skin)
  • MART-1
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Cholangiocarcinoma Trial in Brussels, Beirut, Luxembourg (BMS-936558)

Terminated
  • Cholangiocarcinoma
  • BMS-936558
  • Brussels, Belgium
  • +3 more
Feb 7, 2022

Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558

Completed
Has Results
  • Metastatic Castration-resistant Prostrate Cancer
  • +3 more
  • BMS-936558 (MDX-1106)
  • Scottsdale, Arizona
  • +12 more
Dec 1, 2021

Renal Cell Carcinoma Trial in France, Spain, United States (BMS-936558 (Anti-PD-1))

Completed
Has Results
  • Renal Cell Carcinoma
  • BMS-936558 (Anti-PD-1)
  • San Francisco, California
  • +13 more
Oct 13, 2021

Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Nivolumab+Relatlimab, Nivolumab+Ipilimumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 13, 2022

Cancer Trial in Kashiwa-shi (Relatlimab, Nivolumab)

Active, not recruiting
  • Cancer
  • Kashiwa-shi, Chiba, Japan
    Local Institution
Dec 3, 2021

Meningiomas Trial in Boston (Nivolumab - 240 mg, Ipilimumab - 1 mg/kg, Nivolumab - 480 mg)

Recruiting
  • Meningiomas
  • Nivolumab - 240 mg
  • +4 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 3, 2022

Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Nivolumab, HuMax-IL8, Cabiralizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins University
Jul 28, 2022

Advanced Solid Tumors, NSCLC Trial in Hackensack (BMS-986442, Nivolumab, Docetaxel)

Not yet recruiting
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer
  • BMS-986442
  • +5 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Sep 14, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Advanced Solid Tumors Trial in Shanghai (Relatlimab, Nivolumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Relatlimab
  • Nivolumab
  • Shanghai, Shanghai, China
    Local Institution
Aug 10, 2022

Advanced Cancer Trial in Kashiwa-shi, Kobe-shi (Lirilumab, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • Lirilumab
  • +2 more
  • Kashiwa-shi, Chiba, Japan
  • +1 more
Mar 9, 2022

Advanced Solid Tumors Trial in Canada, United States (BMS-986408, Nivolumab, Ipilimumab)

Recruiting
  • Advanced Solid Tumors
  • Boston, Massachusetts
  • +5 more
Jan 10, 2023

Pediatric Cancer Trial (Nivolumab)

Approved for marketing
  • Pediatric Cancer
  • Nivolumab
  • (no location specified)
Nov 17, 2021

Advanced Cancer Trial in Hangzhou (BMS-986205, Nivolumab)

Completed
Has Results
  • Advanced Cancer
  • Hangzhou, Zhejiang, China
    Local Institution
Feb 3, 2022

Triple Negative Breast Cancer Trial in Saint Louis (drug, biological, procedure)

Recruiting
  • Triple Negative Breast Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 19, 2022

Head Neck Cancer Trial in Houston (Nivolumab)

Recruiting
  • Head and Neck Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 13, 2022

Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Oropharynx Squamous Cell Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 20, 2022

Carcinomas, Renal Medullary Carcinoma Trial in Houston (Nivolumab, Relatlimab)

Not yet recruiting
  • Carcinomas
  • Renal Medullary Carcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Apr 20, 2022

NSCLC Trial in Worldwide (BMS-986315, Nivolumab, Pemetrexed)

Not yet recruiting
  • NSCLC
  • Boise, Idaho
  • +12 more
Oct 17, 2023

Advanced Cancer Trial in Chuo-ku (NKTR-214, Nivolumab)

Completed
  • Advanced Cancer
  • NKTR-214
  • Nivolumab
  • Chuo-ku, Tokyo, Japan
    Local Institution
Oct 1, 2021

Nasopharyngeal Carcinoma Trial in Singapore (Ipilimumab, Nivolumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Singapore, Singapore
    National Cancer Center Singapore
Jul 20, 2022

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Berlin, Germany
    Local Institution - 0001
Aug 9, 2022